Inovio Pharmaceuticals (NYSE AMEX: INO) has teamed up with affiliate VGX International to finance clinical development of the Blue Bell, Pennsylvania-based drug developer’s therapeutic vaccines for hepatitis B and C infections.Under the terms of the deal, VGX will receive marketing rights for the vaccines in Asia, but Inovio will hold onto the lucrative Japanese market. [...]

Biotechnology company Medicago (TSX:MDG) has secured a $5.6 million milestone payment from the federal government as the company nears completion of a new vaccine plant in Research Triangle Park, North Carolina intended to respond to future pandemics.Quebec City, Canada-based Medicago could receive up to $21 million from the Defense Advanced Research Projects Agency, or DARPA, [...]